Waldenström's Macroglobulinaemia

Overview and management of IgM-associated lymphoma.

Reviewed by Dr Kola Tytler MBBS CertHE MBA MSt MRCGP (General Practitioner)

Last reviewed: 21 October 2025

HaematologyOncology

Turn this into CPDPractise this topic, identify learning gaps and prepare a CPD draft you can review.

Clinical Guidelines

ESMO Clinical Practice Guidelines: Waldenström's Macroglobulinaemia

Guidelines on the diagnosis and management of Waldenström macroglobulinaemia

NICE Technology Appraisal Guidance [TA795]: Ibrutinib for treating Waldenstrom's macroglobulinaemia

NICE Technology Appraisal Guidance [TA833]: Zanubrutinib for treating Waldenstrom's macroglobulinaemia

ESMO Clinical Practice Guidelines: Waldenström's macroglobulinaemia – diagnosis, treatment and follow-up

NCCN Clinical Practice Guidelines in Oncology: Waldenström's Macroglobulinaemia/Lymphoplasmacytic Lymphoma (Version 2.2020)